Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem Americas, Inc.
02 2PolyPeptide Laboratories (Sweden) AB
01 2Desmopressin
02 1Desmopressin acetate
01 3Switzerland
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Registration Number : 226MF10051
Registrant's Address : 3132 Kashiwa Street, Torrance, California 90505, USA
Initial Date of Registration : 2014-02-27
Latest Date of Registration : 2014-02-27
Registration Number : 224MF10122
Registrant's Address : Ho(¨)gerudsgatan 21, Limhamn
Initial Date of Registration : 2012-07-09
Latest Date of Registration : 2023-06-28
Registration Number : 306MF10047
Registrant's Address : Ho(¨)gerudsgatan 21, Limhamn
Initial Date of Registration : 2024-03-27
Latest Date of Registration : 2024-03-27
A Desmopressin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desmopressin, including repackagers and relabelers. The FDA regulates Desmopressin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desmopressin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Desmopressin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Desmopressin supplier is an individual or a company that provides Desmopressin active pharmaceutical ingredient (API) or Desmopressin finished formulations upon request. The Desmopressin suppliers may include Desmopressin API manufacturers, exporters, distributors and traders.
click here to find a list of Desmopressin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Desmopressin Drug Master File in Japan (Desmopressin JDMF) empowers Desmopressin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Desmopressin JDMF during the approval evaluation for pharmaceutical products. At the time of Desmopressin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Desmopressin suppliers with JDMF on PharmaCompass.
We have 2 companies offering Desmopressin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
